Live feed08:05:00·7mPRReleasevia QuantisnowIMUNON Reports Independent Data Monitoring Committee Recommends Continued Phase 2 Development of IMNN-001 Following Favorable Safety ReviewByQuantisnow·Wall Street's wire, on your screen.IMNN· Imunon Inc.Health Care
